Galena Lied About Illegal Fentanyl Marketing, Investor Says
A Galena BioPharma Inc. investor on Thursday hit the California-based pharmaceutical company with a derivative suit in New Jersey federal court alleging that its directors misled investors and mismanaged the company...To view the full article, register now.
Already a subscriber? Click here to view full article